These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
703 related articles for article (PubMed ID: 12483965)
1. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients. Kaur I; Dogra S; Kumar B; Radotra BD Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965 [TBL] [Abstract][Full Text] [Related]
2. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin. Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382 [TBL] [Abstract][Full Text] [Related]
3. Disabilities in multibacillary leprosy following multidrug therapy with and without immunotherapy with Mycobacterium w antileprosy vaccine. Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):250-8. PubMed ID: 10575404 [TBL] [Abstract][Full Text] [Related]
4. Impact of combined Mycobacterium w vaccine and 1 year of MDT on multibacillary leprosy patients. De Sarkar A; Kaur I; Radotra BD; Kumar B Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):187-94. PubMed ID: 11875762 [TBL] [Abstract][Full Text] [Related]
5. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy. Katoch K; Katoch VM; Natrajan M; Sreevatsa ; Gupta UD; Sharma VD; Shivanavar CT Vaccine; 2004 Sep; 22(27-28):3649-57. PubMed ID: 15315844 [TBL] [Abstract][Full Text] [Related]
6. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT). Rada E; Ulrich M; Aranzazu N; Rodriguez V; Centeno M; Gonzalez I; Santaella C; Rodriguez M; Convit J Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484 [TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy. Narang T; Kaur I; Kumar B; Radotra BD; Dogra S Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653 [TBL] [Abstract][Full Text] [Related]
8. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine. Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years. Shaw IN; Natrajan MM; Rao GS; Jesudasan K; Christian M; Kavitha M Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):405-9. PubMed ID: 11332283 [TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients. Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888 [TBL] [Abstract][Full Text] [Related]
11. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [TBL] [Abstract][Full Text] [Related]
12. Fixed-duration multidrug therapy in multibacillary leprosy. Li HY; Hu LF; Wu PW; Luo JS; Liu XM Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):230-7. PubMed ID: 9251596 [TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta. Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity. Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255 [TBL] [Abstract][Full Text] [Related]
16. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up. Rao PN; Suneetha S; Pratap DV Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932 [TBL] [Abstract][Full Text] [Related]
17. Are 18 doses of WHO/MDT sufficient for multibacillary leprosy; results of a trial in Malawi. Pönnighaus JM; Boerrigter G Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):1-7. PubMed ID: 7730703 [TBL] [Abstract][Full Text] [Related]
18. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy. Katoch K; Katoch VM; Natrajan M; Bhatia AS; Sreevatsa ; Gupta UD; Sharma VD; Shivannavar CT; Patil MA; Bharadwaj VP Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215 [TBL] [Abstract][Full Text] [Related]
19. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996. Dasananjali K; Schreuder PA; Pirayavaraporn C Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751 [TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy. Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]